Skip to main content
SpringerPlus

Table 6 Prevalence of diabetics and use of lipid lowering drugs or thyroxin preoperatively and 12 months after LSG

From: Energy intake, nutritional status and weight reduction in patients one year after laparoscopic sleeve gastrectomy

 

Preoperative

12 months postoperative

Type 1 diabetes

1%

$

Type 2 diabetes, taking insulin

1%

2%

Type 2 diabetes, medicated

14%

1%†

Type 2 diabetes, dietary regulated

1%

3%

No diabetes

83%

94%†

Lipid lowering drugs

20%

13%

Thyroxin users

14%

15%

  1. McNemar Test was used to compare the prevalence of values below normal reference range between pre and post surgery values.
  2. $One patient with type 1 diabetes was enrolled in the study, and this patient did not complete the 12 month postoperative visit.
  3. †significantly different from preoperatively (p < 0.05).
Back to article page